Latest Reports

Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.

2022 Refractive Error Model, December, 2022

Market Scope’s "2022 Refractive Error Model" offers extensive country-level prevalence data and five-year forecasts for five refractive error categories by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

2022 European Five Ophthalmic Market Report: Regional Analysis for 2021 to 2027, December, 2022

Market Scope’s “2022 European Five Ophthalmic Market Report” analyzes the ophthalmic market in Western Europe’s five largest economies, discussing important trends and key factors for future success in 11 ophthalmic submarkets. The report includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. It profiles ophthalmic companies in the five markets, provides analysis of current markets, and offers five-year forecasts of market performance.

2022 Annual US Diagnostic Equipment Survey Report, December, 2022

Market Scope in Q3-2022 conducted an online survey of US ophthalmologists focused on diagnostic equipment to better understand industry dynamics, gain important insights into leading trends, and explore surgeons’ opinions on current and future technologies. Sponsors were given the opportunity to review survey questions and add additional questions. Email invitations were sent to US ophthalmologists who had been individually confirmed and verified on Market-Scope.com to participate in the survey. There were 100 total complete, unique responses.

2021 Ophthalmic Landscape Report: Global Analysis for 2020 to 2026, December, 2022

The second-edition “2021 Ophthalmic Landscape Report” offers a high-level analysis of the 2021 global ophthalmic market by region and subspecialty and forecasts market performance over the next five years. It discusses important trends and key factors for future success.

US Cataract Quarterly Update

Q4 - 2022

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our US Cataract Surgery Quarterly Updates. These updates are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

Ophthalmic Deals Report

Q4, 2022

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

2022 Corneal Disease Model, December, 2022

Market Scope’s "2022 Corneal Disease Model" offers extensive country-level prevalence data and five-year forecasts for nine corneal diseases for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

US Refractive Quarterly Update

Q4 - 2022

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our US Refractive Surgery Quarterly Updates. These updates are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

US Glaucoma Quarterly Update

Q4 - 2022

Our coverage of the US glaucoma surgery market includes a quarterly surveying process that targets and collects data from glaucoma surgeons. The resulting data are analyzed and presented in our US Glaucoma Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, product use and market share, product adoption plans, and the identification of significant trends in the marketplace for the treatment of glaucoma. 

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

2022 Cornea Products Market Report: Global Analysis for 2021 to 2027, December, 2022

The “2022 Cornea Products Market Report” provides an overview of corneal diseases and gives estimates for the populations in six disease categories. The report discusses cornea products and treatments and revenue forecasts for cornea transplants, therapeutic lenses, PTK, intrastromal corneal ring segments, and corneal crosslinking. It also reviews organ donation policy, regulations, and the role of cornea specialists, eye banks, and other organizations.

This report considers over 70 products from more than 50 companies in its market forecasts and discusses the upcoming pipeline of new technologies that have yet to recognize revenue. Hundreds of eye banks, research institutes, and NGOs are also considered. Also included are 14 in-depth company profiles on key market players.

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more